The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...

Cathy Burgess, Benjamin Wolf, Jong Ho "Philip" Won, Ph.D. The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Data Process Mapping Tools and Strategies in Data Integrity Governance (Sept 5, 2025)" training has been added to ResearchAndMarkets.com's offering. This ...

Dublin, Feb. 17, 2020 (GLOBE NEWSWIRE) -- The "Data Integrity: FDA/EU Requirements and Implementation" conference has been added to ResearchAndMarkets.com's offering. This 2-day course explains the ...

Protecting bioanalytical data integrity from bench to report - A Thermo Fisher Scientific White Paper ...

Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Real-World Quality Management Systems and Data Integrity Compliance Tactics (July 30, 2025)" training has been added to ResearchAndMarkets.com's offering ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--DvSum, a leader in data intelligence management, is pleased to announce its partnership with Booz Allen Hamilton and the U.S. Food and Drug Administration (FDA) to ...

(MENAFN- GlobeNewsWire - Nasdaq) The market opportunities lie in leveraging data process mapping to enhance data integrity and regulatory compliance, particularly aligning with FDA standards. There's ...